YIELD10 BIOSCI Cash Flow - Quarterly (NASDAQ:YTEN)
$1.75 $0.09 (5.42%) YTEN stock closing price Apr 25, 2018 (Closing)
The YIELD10 BIOSCI cash flow statement helps investors understand how well the company is managing its cash flows. This statement shows details about the cash generated and spent during a particular quarter, while the other two statements give details about YIELD10 BIOSCI profits and YIELD10 BIOSCI debt. YIELD10 BIOSCI stock analysis shows negative net income cash flow of $-9.39M till 2017 Q4. This statement is important because profits alone cannot pay employees, or bills. Cash is required. YIELD10 BIOSCI saw a outflow of $- from investing activities till 2017 Q4.
View and download details of YIELD10 BIOSCI cash flows for latest & last 40 quartersshow more
| Fiscal year is Jan - Dec | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | 2016 Q2 | 2016 Q1 | 2015 Q4 | 2015 Q3 |
Net Income Cash Flow | -9.39M | -6.84M | -4.81M | -2.09M | -7.6M | -5.67M | -9.69M | -6.49M | -23.68M | -17.76M |
| Depreciation Depletion Amortization Cash-Flow | - | - | - | - | - | - | - | - | - | - |
| Net Increase (Decrease) in Assets Liabilities | -0.49M | -0.75M | -0.28M | -0.68M | - | - | - | -0.89M | -1.07M | -0.73M |
| Cash From (used in) Discontinued Operations | - | - | - | - | -9.83M | -9.83M | - | - | - | - |
| Other Adjustments Net | 1.48M | 1.13M | - | - | 1.52M | 2.02M | 1.1M | - | 2.62M | 1.94M |
Net Cash from (used by) Operating Activities | -8.2M | -6.3M | -4.28M | -2.43M | -14.7M | -12.26M | -7.89M | -6.52M | -21.86M | -16.39M |
| Increase (Decrease) in Prop Plant And Equipment | -0.01M | -0.01M | - | - | -0.75M | -0.72M | -0.35M | -0.16M | -0.61M | -0.45M |
| Acquisition Disposition of Subsidiaires | - | - | - | - | - | - | - | - | - | - |
| Increase (Decrease) in Investments | - | - | - | - | - | - | - | - | - | - |
| Other Cash Inflow (Outflow) from Investment Activities | - | - | - | - | 10.5M | 10.5M | -0.3M | -0.3M | - | - |
Net Cash from (used by) Investment Activities | - | -0.01M | - | - | 9.75M | 9.78M | -0.66M | -0.46M | -0.61M | -0.45M |
| Issuance (Purchase) of Equity Shares | 15.28M | 1.96M | - | - | - | - | - | - | 14.7M | 14.7M |
| Issuance (Repayment) of Debt Securities | - | - | - | - | - | - | - | - | - | - |
| Increase (Decrease) in Bank & Other Borrowings | - | - | - | - | - | - | - | - | - | - |
| Payment of Dividends & Other Cash Distributions | - | - | - | - | - | - | - | - | - | - |
| Other Cash from (used by) Financing Activities | -0.01M | -0.01M | -0.01M | - | - | - | - | - | - | - |
Net Cash from (used by) Financing Activities | 15.27M | 1.95M | -0.01M | - | - | - | - | - | 14.7M | 14.7M |
| Effect of Exchange Rate Changes on Cash | - | - | - | - | -0.01M | -0.01M | -0.01M | - | - | - |
Net Change in Cash & Cash Equivalents | 7.17M | -4.35M | -4.29M | -2.43M | -4.96M | -2.48M | -8.56M | -6.99M | -7.77M | -2.15M |
| Cash & Equivalents at Beginning of Year | 7.3M | 12.26M | 20.04M | 7.69M | 14.57M | 21.27M | 12.52M | 10.81M | 26.19M | 22.68M |
| Cash & Equivalents at Year End | 14.48M | 2.95M | 3.01M | 4.87M | 7.3M | 9.78M | 3.7M | 5.27M | 12.26M | 17.89M |
All figures in USD. M: Millions of USD, B: Billions of USD.
View Next Quarters
Click here to view our Honeywell financial analysis
While YIELD10 BIOSCI stock price history provides the price history of a stock, YIELD10 BIOSCI stock comparison chart shows the same in comparison to peers, and cash flow statements provide cash position of the company. Common terms used in the statement of cash flows are:
- YIELD10 BIOSCI has cash of $14.48M on hand. A healthy amount of cash on hand is necessary for any company. Cash has an opportunity cost associated with it, and too much cash in bank may mean that the firm has no or limited growth plans. Hence its important to track the Net Change in Cash and Cash Equivalents along with the YIELD10 BIOSCI stock price.
- Cash Flow from operating activities: This is the cash that the company receives from ongoing operations. YIELD10 BIOSCI lost $-8.2M cash from operations. It is important to check this to see where the company is getting its money from.
- Growth companies, typically most tech companies; spend heavily on investing activities and this figure stood at $- for YTEN stock. Sometimes a company might have a negative overall cash flow which may not be really bad if it is due to investment expenses. Hence it is important to check the cash flow from investment activities.
- Cash Flow from financing activities: The cash inflow/outflow from financing activities was $15.27M for YIELD10 BIOSCI. The money accounted for under this head comes from external sources which includes lenders, investors and shareholders. Positive cash flow is generated when the company gets cash because of issuance of stocks or bonds. Similarly negative cash flow is generated when shares are repurchased, dividend payments are made, and loans or interest on loans are paid back.